Publications by authors named "Tim Kopotsha"

Claim this Profile
P
Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma.
Marie Toukam, Jens Wuerthner, Karin Havenith, Mehdi Hamadani, Paolo F Caimi, Tim Kopotsha

Cancer Chemother Pharmacol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding.
Emma Davé, Ralph Adams, Oliver Zaccheo, Bruce Carrington, Joanne E Compson, Tim Kopotsha

MAbs· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer.
Charlene Porter, Sylvia Armstrong-Fisher, Tim Kopotsha, Bryan Smith, Terry Baker

J Reprod Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis